Cargando…
Treatment of Gastrointestinal Stromal Tumors (GISTs): A Focus on Younger Patients
SIMPLE SUMMARY: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the gastrointestinal tract. GISTs mainly develop in older adults, and the median age of diagnosis is 60–65 years. The incidence of GISTs in young adult patients, defined as adults before 40, is less...
Autores principales: | Dudzisz-Śledź, Monika, Klimczak, Anna, Bylina, Elżbieta, Rutkowski, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221273/ https://www.ncbi.nlm.nih.gov/pubmed/35740497 http://dx.doi.org/10.3390/cancers14122831 |
Ejemplares similares
-
Treatment of Metastatic Gastrointestinal Stromal Tumors (GIST): A Focus on Older Patients
por: Dudzisz-Śledź, Monika, et al.
Publicado: (2021) -
The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST)*
por: Rutkowski, Piotr, et al.
Publicado: (2017) -
The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study
por: Rutkowski, Piotr, et al.
Publicado: (2012) -
Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies
por: Stachyra, Karolina, et al.
Publicado: (2021) -
Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib
por: Quek, Richard, et al.
Publicado: (2010)